AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

TCLARKE PLC

Declaration of Voting Results & Voting Rights Announcements Jun 3, 2019

4611_rns_2019-06-03_b3740a5f-4b26-4ad2-96ba-206a886866c5.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9214A

TClarke PLC

03 June 2019

TClarke plc

Total Voting Rights and Share Capital

In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1R, TClarke plc ("the Company") provides the following updated information:

As at 31 May 2019, the Company's issued share capital consists of 43,030,882 ordinary shares of 10p, each with equal voting rights. The Company does not hold any shares in Treasury, therefore, the total voting rights in the Company as at that date was 43,030,882.

The above figure may be used by shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Date: 3 June 2019

For further information contact:

TClarke plc

Mark Lawrence - Group Chief Executive

Trevor Mitchell - Finance Director

David Lanchester - Company Secretary

Tel: 020 7997 7400

www.tclarke.co.uk

N+1 Singer (Financial Adviser and Broker)

Sandy Fraser

Rachel Hayes

Tel: 020 7496 3000

www.nplus1singer.com

RMS Partners

Simon Courtenay

Tel: 020 3735 6551

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

TVRFJMLTMBMMMTL

Talk to a Data Expert

Have a question? We'll get back to you promptly.